Cannabinoid Receptor 2 Agonist Attenuates Pain Related Behavior in Rats with Chronic Alcohol/High Fat Diet Induced Pancreatitis

Molecular Pain

Volumn 10, Issue , 2014, Pages

  Zhang, Liping ^a   Kline, Robert H ^a   McNearney, Terry A ^b   Johnson, Michael P ^b   Westlund, Karin N ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

44 C hotplate test; Alcohol; Behavioral testing; CB2; High fat; Hyperalgesia; Ki67; Pain; Pancreas; Tissue repair

Indexed keywords

ALCOHOL DERIVATIVE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST;

ADVERSE EFFECTS; AGONISTS; ANIMAL; CELL PROLIFERATION; COMPLICATION; DARK ADAPTATION; DISEASE MODEL; DRUG EFFECTS; EXPLORATORY BEHAVIOR; FIBROSIS; FISCHER 344 RAT; HYPERALGESIA; LIPID DIET; MALE; PAIN THRESHOLD; PANCREATITIS, CHRONIC; PATHOLOGY; RAT; REACTION TIME; SEVERITY OF ILLNESS INDEX; VISCERAL PAIN;

ALCOHOLS; ANIMALS; CANNABINOID RECEPTOR AGONISTS; CELL PROLIFERATION; DARK ADAPTATION; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FIBROSIS; HYPERALGESIA; MALE; PAIN THRESHOLD; PANCREATITIS, CHRONIC; RATS; RATS, INBRED F344; REACTION TIME; RECEPTOR, CANNABINOID, CB1; SEVERITY OF ILLNESS INDEX; VISCERAL PAIN;

EID: 84925287131     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-10-66     Document Type: Article

References (59)

1. Pasricha PJ: Unraveling the mystery of pain in chronic pancreatitis. Nat Rev Gastroenterol Hepatol 2012, 9:140–151.
2. Whitcomb DC Yadav D Adam S Hawes RH Brand RE Anderson MA Money ME Banks PA Bishop MD Baillie J Sherman S DiSario J Burton FR Gardner TB Amann ST Gelrud A Lo SK DeMeo MT Steinberg WM Kochman ML Etemad B Forsmark CE Elinoff B Greer JB O'Connell M Lamb J Barmada MM, North American Pancreatic Study Group: Multicenter approach to recurrent acute and chronic pancreatitis in the United States: The North American Pancreatitis Study 2 (NAPS2). Pancreatology 2008, 8:520–531.
3. Mounzer R Whitcomb DC: Genetics of acute and chronic pancreatitis. Curr Opin Gastroenterol 2013, 29:544–551.
4. Coté GA Yadav D Slivka A Hawes RH Anderson MA Burton FR Brand RE Banks PA Lewis MD Disario JA Gardner TB Gelrud A Amann ST Baillie J Money ME O'Connell M Whitcomb DC Sherman S, North American Pancreatitis Study Group: Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis. Clin Gastroenterol Hepatol 2011, 9:266–273. quiz e227.
5. Whitcomb DC LaRusch J Krasinskas AM Klei L Smith JP Brand RE Neoptolemos JP Lerch MM Tector M Sandhu BS Guda NM Orlichenko L Disease Genetics Consortium Alzheimer's Alkaade S Amann ST Anderson MA Baillie J Banks PA Conwell D Coté GA Cotton PB DiSario J Farrer LA Forsmark CE Johnstone M Gardner TB Gelrud A Greenhalf W Haines JL Hartman DJ et al.: Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet 2012, 44:1349–1354.
6. Pacher P Mechoulam R: Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog Lipid Res 2011, 50:193–211.
7. Atwood BK Mackie K: CB2: A cannabinoid receptor with an identity crisis. Br J Pharmacol 2010, 160:467–479.
8. Li C Bowe JE Jones PM Persaud SJ: Expression and function of cannabinoid receptors in mouse islets. Islets 2010, 2:293–302.
9. Linari G Agostini S Amadoro G Ciotti MT Florenzano F Improta G Petrella C Severini C Broccardo M: Involvement of cannabinoid CB1- and CB2-receptors in the modulation of exocrine pancreatic secretion. Pharmacol Res 2009, 59:207–214.
10. Elphick MR Egertova M: The neurobiology and evolution of cannabinoid signalling. Philos Trans R Soc Lond B Biol Sci 2001, 356:381–408.
11. Pacher P Kunos G: Modulating the endocannabinoid system in human health and disease–successes and failures. FEBS J 2013, 280:1918–1943.
12. Cabral GA Griffin-Thomas L: Cannabinoids as therapeutic agents for ablating neuroinflammatory disease. Endocr Metab Immune Disord Drug Targets 2008, 8:159–172.
13. Han S Thatte J Buzard DJ Jones RM: Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists. J Med Chem 2013, 56:8224–8256.
14. Cabral GA Griffin-Thomas L: Emerging role of the cannabinoid receptor CB2 in immune regulation: Therapeutic prospects for neuroinflammation. Expert Rev Mol Med 2009, 11:e3.
15. Cabral GA Raborn ES Griffin L Dennis J Marciano-Cabral F: CB2 receptors in the brain: Role in central immune function. Br J Pharmacol 2008, 153:240–251.
16. Raborn ES Marciano-Cabral F Buckley NE Martin BR Cabral GA: The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: Linkage to the CB2 receptor. J Neuroimmune Pharmacol 2008, 3:117–129.
17. Palazuelos J Aguado T Egia A Mechoulam R Guzman M Galve-Roperh I: Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation. FASEB J 2006, 20:2405–2407.
18. Fernandez-Ruiz J Romero J Velasco G Tolon RM Ramos JA Guzman M: Cannabinoid CB2 receptor: A new target for controlling neural cell survival? Trends Pharmacol Sci 2007, 28:39–45.
19. Guindon J Hohmann AG: Cannabinoid CB2 receptors: A therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharmacol 2008, 153:319–334.
20. Nackley AG Suplita RL 2nd Hohmann AG: A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience 2003, 117:659–670.
21. Mazzari S Canella R Petrelli L Marcolongo G Leon A: N-(2-hydroxyethyl) hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol 1996, 300:227–236.
22. Piomelli D Sasso O: Peripheral gating of pain signals by endogenous lipid mediators. Nat Neurosci 2014, 17:164–174.
23. Michalski CW Laukert T Sauliunaite D Pacher P Bergmann F Agarwal N Su Y Giese T Giese NA Batkai S Friess H Kuner R: Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis. Gastroenterology 2007, 132:1968–1978.
24. Michler T Storr M Kramer J Ochs S Malo A Reu S Goke B Schafer C: Activation of cannabinoid receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms. Am J Physiol Gastrointest Liver Physiol 2013, 304:G181–G192.
25. Ohta T Terada T Nagakawa T Itoh H Tajima H Miyazaki I: Presence of pancreatic alpha-amylase, trypsinogen, and lipase immunoreactivity in normal human pancreatic ducts. Pancreas 1994, 9:382–386.
26. Noronha M Salgadinho A De Almeida Ferreira MJ Dreiling DA Bordalo O: Alcohol and the pancreas. I. Clinical associations and histopathology of minimal pancreatic inflammation. Am J Gastroenterol 1981, 76:114–119.
27. Noronha M Bordalo O Dreiling DA: Alcohol and the pancreas. II. Pancreatic morphology of advanced alcoholic pancreatitis. Am J Gastroenterol 1981, 76:120–124.
28. Koh SL Tan JW Muralidharan V Christophi C: The effect of hyperbaric oxygen on apoptosis and proliferation in severe acute pancreatitis. HPB (Oxford) 2009, 11:629–637.
29. Sakaguchi Y Inaba M Kusafuka K Okazaki K Ikehara S: Establishment of animal models for three types of pancreatitis and analyses of regeneration mechanisms. Pancreas 2006, 33:371–381.
30. Silva A Weber A Bain M Reding T Heikenwalder M Sonda S Graf R: COX-2 is not required for the development of murine chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol 2011, 300:G968–G975.
31. Badescu A Lae M Morin AS Handra-Luca A: Ileal leiomyosarcoma and lymph node granuloma. Relevance of a rare association. Clin Res Hepatol Gastroenterol 2012, 36:e96–e99.
32. Borrelli F Fasolino I Romano B Capasso R Maiello F Coppola D Orlando P Battista G Pagano E Di Marzo V Izzo AA: Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. Biochem Pharmacol 2013, 85:1306–1316.
33. Rutishauser SC Ali AE Jeffrey IJ Hunt LP Braganza JM: Toward an animal model of chronic pancreatitis. Pancreatobiliary secretion in hamsters on long-term treatment with chemical inducers of cytochromes P450. Int J Pancreatol 1995, 18:117–126.
34. Leleu-Chavain N Body-Malapel M Spencer J Chavatte P Desreumaux P Millet R: Recent advances in the development of selective CB(2) agonists as promising anti-inflammatory agents. Curr Med Chem 2012, 19:3457–3474.
35. Quartilho A Mata HP Ibrahim MM Vanderah TW Porreca F Makriyannis A Malan TP Jr: Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Anesthesiology 2003, 99:955–960.
36. Harrington GM: The Har strains of rats: Origins and characteristics. Behav Genet 1981, 11:445–468.
37. Rex A Sondern U Voigt JP Franck S Fink H: Strain differences in fear-motivated behavior of rats. Pharmacol Biochem Behav 1996, 54:107–111.
38. Costall B Kelly ME Onaivi ES Naylor RJ: The effect of ketotifen in rodent models of anxiety and on the behavioural consequences of withdrawing from treatment with drugs of abuse. Naunyn Schmiedebergs Arch Pharmacol 1990, 341:547–551.
39. Bilkei-Gorzo A Gyertyan I Levay G: mCPP-induced anxiety in the light–dark box in rats–a new method for screening anxiolytic activity. Psychopharmacology (Berl) 1998, 136:291–298.
40. Botting SK Frye GD Pulido MD McCool BA: Effects of chronic alcohol ingestion on rat lateral/basolateral amygdala ligand-gated chloride channels. Ann N Y Acad Sci 2003, 985:479–480.
41. Hughes RN: Adult anxiety-related behavior of rats following consumption during late adolescence of alcohol alone and in combination with caffeine. Alcohol 2011, 45:365–372.
42. McCool BA Frye GD Pulido MD Botting SK: Effects of chronic ethanol consumption on rat GABA(A) and strychnine-sensitive glycine receptors expressed by lateral/basolateral amygdala neurons. Brain Res 2003, 963:165–177.
43. Wang ZY Wang P Bjorling DE: Activation of cannabinoid receptor 2 inhibits experimental cystitis. Am J Physiol Regul Integr Comp Physiol 2013, 304:R846–R853.
44. Kikuchi A Ohashi K Sugie Y Sugimoto H Omura H: Pharmacological evaluation of a novel cannabinoid 2 (CB2) ligand, PF-03550096, in vitro and in vivo by using a rat model of visceral hypersensitivity. J Pharmacol Sci 2008, 106:219–224.
45. Demols A Van Laethem JL Quertinmont E Degraef C Delhaye M Geerts A Deviere J: Endogenous interleukin-10 modulates fibrosis and regeneration in experimental chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol 2002, 282:G1105–G1112.
46. van Westerloo DJ Florquin S de Boer AM Daalhuisen J de Vos AF Bruno MJ van der Poll T: Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice. Am J Pathol 2005, 166:721–728.
47. Hadi AM Mouchaers KT Schalij I Grunberg K Meijer GA Vonk-Noordegraaf A van der Laarse WJ Belien JA: Rapid quantification of myocardial fibrosis: A new macro-based automated analysis. Anal Cell Pathol (Amst) 2010, 33:257–269.
48. Kimura W Okubo K Han I Kanai S Matsushita A Muto T Miyasaka K: Effects of pancreatic duct ligation and aging on acute taurocholate-induced pancreatitis. Experiments in the perfused pancreas in rats. Int J Pancreatol 1996, 19:117–127.
49. Chaplan SR Bach FW Pogrel JW Chung JM Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53:55–63.
50. Dixon WJ: Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 1980, 20:441–462.
51. Vera-Portocarrero LP Lu Y Westlund KN: Nociception in persistent pancreatitis in rats: Effects of morphine and neuropeptide alterations. Anesthesiology 2003, 98:474–484.
52. Vierck CJ Jr Kline R Wiley RG: Comparison of operant escape and innate reflex responses to nociceptive skin temperatures produced by heat and cold stimulation of rats. Behav Neurosci 2004, 118:627–635.
53. Yeomans DC Proudfit HK: Characterization of the foot withdrawal response to noxious radiant heat in the rat. Pain 1994, 59:85–94.
54. Espejo EF Mir D: Structure of the rat's behaviour in the hot plate test. Behav Brain Res 1993, 56:171–176.
55. Espejo EF Stinus L Cador M Mir D: Effects of morphine and naloxone on behaviour in the hot plate test: An ethopharmacological study in the rat. Psychopharmacology (Berl) 1994, 113:500–510.
56. Palecek J Paleckova V Willis WD: The roles of pathways in the spinal cord lateral and dorsal funiculi in signaling nociceptive somatic and visceral stimuli in rats. Pain 2002, 96:297–307.
57. Mills CD Grady JJ Hulsebosch CE: Changes in exploratory behavior as a measure of chronic central pain following spinal cord injury. J Neurotrauma 2001, 18:1091–1105.
58. Zhang L Zhang X Westlund KN: Restoration of spontaneous exploratory behaviors with an intrathecal NMDA receptor antagonist or a PKC inhibitor in rats with acute pancreatitis. Pharmacol Biochem Behav 2004, 77:145–153.
59. Crawley J Goodwin FK: Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 1980, 13:167–170.